Dr. Christopher MacDonald Debacker, MD

Dr. Debacker practices at South Texas Ambulatory Surgery Center in San Antonio, Texas.

Dr. Debacker's NPI, 1316905839, was assigned on May 3, 2006. Dr. Debacker graduated from Icahn School Of Medicine At Mount Sinai in 1991. Dr. Debacker holds Texas license N5646.

Dr. Debacker's primary practice is South Texas Ambulatory Surgery Center, at 9238 Floyd Curl Drive Suite 100, San Antonio, TX 78240. The practice phone is (210) 696-0500.

Dr. Debacker's primary practice is South Texas Ambulatory Surgery Center in San Antonio, Texas. Dmand AI also links Dr. Debacker to 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Debacker practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Debacker's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Debacker is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Debacker's licenses on file in 6 states: Texas, Arizona, Idaho, California, Florida and North Carolina.

Dmand AI lists cataract, eye infection or inflammation, eyelid inflammation, shingles and vision problems among the conditions Dr. Debacker treats.

CMS data shows 10,403 Medicare services from Dr. Debacker across 19 procedure codes in 2024, for 639 Medicare patients. Medicare paid $333,304 for them.

CMS counts 639 Medicare patients who saw Dr. Debacker in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Debacker's median patient age at 71, with 66% women.

In 2024, Dr. Debacker wrote 1,786 Medicare Part D claims for 718 patients. 88% of them were for generic drugs. CMS names the drug for 1,728 of them, across 11 drugs with 11 or more claims each, at $36,430 in total drug cost. In 2023, CMS named 1,491 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Debacker for performance year 2024, reported as part of a group. Dr. Debacker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Debacker, published from 2021 to 2024. The most frequent topics are Eyelids, Blepharoplasty and Cattle. Dr. Debacker has published most often in Ophthalmic Plast Reconstr Surg. Dr. Debacker's most frequent co-authors are David Edward Holck, MD, Wesley Brundridge, DO and Gregg S. Gayre, MD.

CMS Open Payments shows 186 general payments to Dr. Debacker from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Horizon Pharma plc paid the most, $1,136.

Dmand AI lists 4 awards for Dr. Debacker, most recently Top Doctors:SE Texas in 2013.

Dr. Debacker graduated from Icahn School Of Medicine At Mount Sinai in 1991. Dr. Debacker is a member of AAO and ACS.

Dr. Debacker is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.